Cabazitaxel is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug and classified as a "taxane derivitive" and an "anti-microtubule agent." It is approved for treatment for treatment of patients with castrate resistant metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.
Nausea: feeling of need to vomit, Constipation: hardened feces , delayed passage of feces . Low-blood count: decrease in white and red blood count for temporarily, Fever: if fever is above 100.4 F consult doctor.
Related Journals of Cabazitaxel